Keyphrases
Activity State
7%
Age at Diagnosis
21%
American College of Rheumatology
10%
Clinician-reported Outcomes
11%
COVID-19
23%
COVID-19 Pandemic
14%
Damage Accrual
30%
Damage Index
21%
Disease Activity
22%
Disease Activity Score
14%
Disease Duration
24%
Emotional Health
11%
Fear of Coronavirus
11%
Fear of COVID-19 Scale (FCV-19S)
7%
Health-related Quality of Life
48%
Homocysteine Levels
11%
Hospitalization
7%
Immunosuppressive Drugs
7%
Latin American
19%
Living with
11%
Low Disease Activity State
11%
Lupus
85%
Lupus Low Disease Activity State (LLDAS)
14%
LupusQoL
10%
Medical Students
23%
Mental Health
8%
Mestizo
8%
Multivariable
14%
Multivariable Model
8%
Numerical Rating Scale
9%
Patient Data
17%
Patient-Reported Outcomes Measurement Information System (PROMIS)
7%
Peru
9%
Peruvian
46%
Physical Health
9%
Prednisone
11%
Psychometric Properties
11%
Rapid Evaluation
11%
Regression Analysis
6%
Remission
21%
Rheumatic Diseases
11%
Rheumatology
14%
Single Center
10%
SLE Disease Activity Index (SLEDAI)
37%
SLICC
11%
Spanish Version
11%
Systemic Lupus Erythematosus
78%
Systemic Lupus Erythematosus Patient
50%
Systemic Lupus International Collaborating Clinics
15%
Visual Analog Scale
16%
Medicine and Dentistry
Antimalarial Agent
9%
Catatonia
5%
Clinician
6%
COVID-19
11%
Disease
9%
Disease Activity
42%
Disease Activity Score
5%
Disease Duration
15%
Emotional Stability
8%
Frailty Index
5%
Glucocorticoid
6%
Homocysteine
11%
Immunosuppressive Drug
7%
Lupus Erythematosus
73%
Lupus Nephritis
5%
Mental Health
5%
Meta-Regression
5%
Metabolic Syndrome
5%
Numeric Rating Scale
7%
Observational Study
6%
Patient-Data
11%
Personal Experience
5%
Prednisone
9%
Psychiatry
5%
Quality of Life
40%
Rheumatic Disease
9%
Rheumatology
19%
Rituximab
5%
Self Concept
5%
SLEDAI
23%
Susac Syndrome
5%
Systematic Review
5%
Systemic Lupus Erythematosus
100%
Uric Acid
5%
Visual Analog Scale
11%
